Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

After watching her weight go up and down throughout her career, Whitley was recommended the injectable prescription medicine ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without ...